Cargando…
NRF3 upregulates gene expression in SREBP2-dependent mevalonate pathway with cholesterol uptake and lipogenesis inhibition
Lipids, such as cholesterol and fatty acids, influence cell signaling, energy storage, and membrane formation. Cholesterol is biosynthesized through the mevalonate pathway, and aberrant metabolism causes metabolic diseases. The genetic association of a transcription factor NRF3 with obesity has been...
Autores principales: | Waku, Tsuyoshi, Hagiwara, Toru, Tamura, Natsuko, Atsumi, Yuri, Urano, Yasuomi, Suzuki, Mikiko, Iwami, Takuya, Sato, Katsuya, Yamamoto, Masayuki, Noguchi, Noriko, Kobayashi, Akira |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8506969/ https://www.ncbi.nlm.nih.gov/pubmed/34667945 http://dx.doi.org/10.1016/j.isci.2021.103180 |
Ejemplares similares
-
Targeting SREBP-2-Regulated Mevalonate Metabolism for Cancer Therapy
por: Xue, Linyuan, et al.
Publicado: (2020) -
MBTPS2 acts as a regulator of lipogenesis and cholesterol synthesis through SREBP signalling in prostate cancer
por: Tibbo, Amy J., et al.
Publicado: (2023) -
Targeting SREBP-1-Mediated Lipogenesis as Potential Strategies for Cancer
por: Zhao, Qiushi, et al.
Publicado: (2022) -
Nifedipine Modulates Renal Lipogenesis via the AMPK-SREBP Transcriptional Pathway
por: Lin, Yen-Chung, et al.
Publicado: (2019) -
Cdk8 attenuates lipogenesis by inhibiting SREBP-dependent transcription in Drosophila
por: Li, Xiao, et al.
Publicado: (2022)